Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 21,751,284 | 21,751,284 | 0 | $1.24B | $1.31B | 32.87% | +$73.74M |
| Revolution Medicines, Inc.(RVMD) | 3,981,212 | 5,981,212 | +2,000,000 | $110.20M | $171.54M | 4.29% | +$61.34M |
| Axsome Therapeutics, Inc.(AXSM) | 2,131,100 | 1,981,100 | -150,000 | $148.94M | $157.68M | 3.95% | +$8.73M |
| Protagonist Therapeutics Inc | 5,744,848 | 5,744,848 | 0 | $95.82M | $131.73M | 3.30% | +$35.91M |
| Kymera Therapeutics, Inc.(KYMR) | 4,739,004 | 5,161,801 | +422,797 | $65.87M | $131.42M | 3.29% | +$65.55M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 4,370,024 | 4,370,024 | 0 | $138.09M | $129.00M | 3.23% | -$9.09M |
| Olema Pharmaceuticals, Inc.(OLMA) | 9,135,893 | 9,135,893 | 0 | $112.83M | $128.18M | 3.21% | +$15.35M |
| Ionis Pharmaceuticals, Inc.(IONS) | 4,004,613 | 2,428,613 | -1,576,000 | $181.65M | $122.86M | 3.07% | -$58.79M |
| Kura Oncology, Inc.(KURA) | 6,730,983 | 7,373,228 | +642,245 | $61.39M | $106.03M | 2.65% | +$44.64M |
| 4d Molecular Therapeutics In | 4,007,413 | 4,007,413 | 0 | $51.01M | $81.19M | 2.03% | +$30.18M |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,915,109 | 1,915,109 | 0 | $66.17M | $77.85M | 1.95% | +$11.68M |
| Merus N V | 2,752,420 | 2,752,420 | 0 | $64.90M | $75.69M | 1.89% | +$10.79M |
| Repare Therapeutics Inc | 8,291,988 | 10,333,600 | +2,041,612 | $100.17M | $75.44M | 1.89% | -$24.73M |
| AC Immune SASHS(ACIU) | 7,428,379 | 14,571,236 | +7,142,857 | $21.17M | $72.86M | 1.82% | +$51.69M |
| Centessa Pharmaceuticals PlcADS | 9,103,054 | 8,774,570 | -328,484 | $58.90M | $69.85M | 1.75% | +$10.95M |
| Xoma Corp Del | 3,633,743 | 3,633,743 | 0 | $51.20M | $67.22M | 1.68% | +$16.02M |
| IDEAYA Biosciences, Inc.(IDYA) | 5,283,489 | 1,729,043 | -3,554,446 | $142.55M | $61.52M | 1.54% | -$81.03M |
| Zymeworks Inc.(ZYME) | 5,870,000 | 5,870,000 | 0 | $37.22M | $60.99M | 1.53% | +$23.77M |
| GH Research PLC(GHRS) | 9,275,158 | 10,400,158 | +1,125,000 | $93.22M | $60.32M | 1.51% | -$32.89M |
| Essa Pharma Inc | 8,748,629 | 8,748,629 | 0 | $27.03M | $57.74M | 1.45% | +$30.71M |
| Janux Therapeutics, Inc.(JANX) | 4,579,818 | 4,579,818 | 0 | $46.16M | $49.14M | 1.23% | +$2.98M |
| Third Harmonic Bio Inc | 4,365,933 | 4,365,933 | 0 | $27.90M | $47.89M | 1.20% | +$20.00M |
| 89bio Inc | 1,846,154 | 4,047,354 | +2,201,200 | $28.50M | $45.21M | 1.13% | +$16.70M |
| Relay Therapeutics, Inc.(RLAY) | 2,365,805 | 3,970,045 | +1,604,240 | $19.90M | $43.71M | 1.09% | +$23.81M |
| Xenon Pharmaceuticals Inc.(XENE) | 1,827,958 | 890,072 | -937,886 | $62.44M | $41.00M | 1.03% | -$21.45M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 1,875,000 | +1,875,000 | $0 | $40.52M | 1.01% | +$40.52M |
| Tyra Biosciences, Inc.(TYRA) | 2,739,595 | 2,739,595 | 0 | $37.72M | $37.94M | 0.95% | +$219.2K |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 19,995,332 | 24,435,632 | +4,440,300 | $21.79M | $37.39M | 0.94% | +$15.59M |
| Structure Therapeutics IncADS | 1,750,000 | 812,988 | -937,012 | $88.23M | $33.14M | 0.83% | -$55.10M |
| Cullinan Therapeutics, Inc.(CGEM) | 3,196,701 | 3,196,701 | 0 | $28.93M | $32.57M | 0.82% | +$3.64M |
| An2 Therapeutics Inc | 1,563,963 | 1,563,963 | 0 | $25.15M | $32.05M | 0.80% | +$6.90M |
| Annexon, Inc.(ANNX) | 0 | 7,000,000 | +7,000,000 | $0 | $31.78M | 0.80% | +$31.78M |
| Roivant Sciences Ltd.SHS(ROIV) | 2,742,409 | 2,742,409 | 0 | $32.03M | $30.80M | 0.77% | -$1.23M |
| Silence Therapeutics plcADS(SLN) | 1,508,416 | 1,508,416 | 0 | $14.83M | $26.20M | 0.66% | +$11.37M |
| Allakos Inc | 8,552,417 | 8,552,417 | 0 | $19.41M | $23.35M | 0.58% | +$3.93M |
| Glycomimetics Inc | 9,544,262 | 9,544,262 | 0 | $14.32M | $22.52M | 0.56% | +$8.21M |
| Ovid Therapeutics Inc.(OVID) | 6,851,051 | 6,851,051 | 0 | $26.31M | $22.06M | 0.55% | -$4.25M |
| Engene Holdings Inc COM | 0 | 2,251,037 | +2,251,037 | $0 | $20.78M | 0.52% | +$20.78M |
| Calliditas Therapeutics AbADS | 750,000 | 750,000 | 0 | $13.70M | $19.33M | 0.48% | +$5.63M |
| TScan Therapeutics, Inc.(TCRX) | 2,989,474 | 2,989,474 | 0 | $7.65M | $17.43M | 0.44% | +$9.78M |
| Newamsterdam Pharma Company ORDINARY SHARES | 1,521,948 | 1,521,948 | 0 | $14.08M | $17.00M | 0.43% | +$2.92M |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 687,080 | +687,080 | $0 | $14.79M | 0.37% | +$14.79M |
| Sutro Biopharma, Inc.(STRO) | 3,347,946 | 3,347,946 | 0 | $11.62M | $14.36M | 0.36% | +$2.75M |
| Iteos Therapeutics Inc | 1,259,476 | 1,259,476 | 0 | $13.79M | $13.79M | 0.35% | $0 |
| Verastem, Inc.(VSTM) | 1,685,219 | 1,685,219 | 0 | $13.70M | $13.72M | 0.34% | +$16.9K |
| Immunovant, Inc.(IMVT) | 300,000 | 300,000 | 0 | $11.52M | $12.64M | 0.32% | +$1.12M |
| Vistagen Therapeutics, Inc.(VTGN) | 0 | 2,000,000 | +2,000,000 | $0 | $10.28M | 0.26% | +$10.28M |
| CytomX Therapeutics, Inc.(CTMX) | 6,595,801 | 6,595,801 | 0 | $8.51M | $10.22M | 0.26% | +$1.71M |
| Ikena Oncology Inc | 3,169,164 | 4,769,164 | +1,600,000 | $13.72M | $9.40M | 0.24% | -$4.33M |
| Verve Therapeutics Inc | 650,000 | 650,000 | 0 | $8.62M | $9.06M | 0.23% | +$442.0K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 4,326,710 | 4,326,710 | 0 | $5.93M | $7.79M | 0.19% | +$1.86M |
| SAB Biotherapeutics, Inc.(SABS) | 0 | 9,178,282 | +9,178,282 | $0 | $6.31M | 0.16% | +$6.31M |
| Vigil Neuroscience Inc | 1,813,633 | 1,813,633 | 0 | $9.78M | $6.13M | 0.15% | -$3.65M |
| Cidara Therapeutics Inc | 6,861,127 | 6,861,127 | 0 | $6.46M | $5.45M | 0.14% | -$1.02M |
| Rain Oncology Inc | 3,526,729 | 3,526,729 | 0 | $3.04M | $4.23M | 0.11% | +$1.19M |
| Delcath Systems, Inc.(DCTH) | 976,149 | 976,149 | 0 | $3.95M | $4.06M | 0.10% | +$107.4K |
| Pieris Pharmaceuticals Inc | 20,609,863 | 20,609,863 | 0 | $6.14M | $3.75M | 0.09% | -$2.39M |
| Kronos Bio Inc | 2,905,043 | 2,905,043 | 0 | $3.78M | $3.63M | 0.09% | -$145.3K |
| Nls Pharmaceutics LtdSHS | 5,747,126 | 5,747,126 | 0 | $3.97M | $3.39M | 0.08% | -$580.5K |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $2.88M | $3.07M | 0.08% | +$192.1K |
| Forte Biosciences Inc | 2,982,105 | 2,982,105 | 0 | $1.97M | $2.45M | 0.06% | +$476.2K |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,370,947 | 1,370,947 | 0 | $2.00M | $2.41M | 0.06% | +$411.3K |
| Viracta Therapeutics Inc | 3,614,662 | 3,614,662 | 0 | $3.76M | $2.06M | 0.05% | -$1.70M |
| Molecular Templates Inc | 532,038 | 532,038 | 0 | $3.36M | $1.97M | 0.05% | -$1.39M |
| Unicycive Therapeutics Inc | 3,413,563 | 2,118,139 | -1,295,424 | $2.94M | $1.84M | 0.05% | -$1.10M |
| Molecular Partners AGADS(MOLN) | 443,221 | 443,221 | 0 | $1.77M | $1.76M | 0.04% | -$4.4K |
| Elevation Oncology Inc | 2,312,200 | 2,312,200 | 0 | $1.53M | $1.24M | 0.03% | -$290.4K |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 0 | 945,402 | +945,402 | $0 | $803.6K | 0.02% | +$803.6K |
| Aslan Pharmaceuticals LtdADS | 1,049,999 | 1,049,999 | 0 | $1.94M | $548.2K | 0.01% | -$1.39M |
| Rezolute, Inc.(RZLT) | 190,815 | 190,815 | 0 | $251.9K | $189.4K | 0.00% | -$62.5K |
| ACLARIS THERAPEUTICS INCCOM(ACRS) | 7,064,736 | 0 | -7,064,736 | $48.39M | $0 | — | -$48.39M |
| BIONOMICS LIMITEDADS | 47,372 | 0 | -47,372 | $127.9K | $0 | — | -$127.9K |
| IMMUNIC INCCOM(IMUX) | 1,149,425 | 0 | -1,149,425 | $1.69M | $0 | — | -$1.69M |
| JASPER THERAPEUTICS INCCOM(JSPR) | 9,900,000 | 0 | -9,900,000 | $6.93M | $0 | — | -$6.93M |
| POINT BIOPHARMA GLOBAL INCCOM | 10,563,748 | 0 | -10,563,748 | $70.46M | $0 | — | -$70.46M |
| REPLIMUNE GROUP INCCOM(REPL) | 2,143,036 | 0 | -2,143,036 | $36.67M | $0 | — | -$36.67M |